Thomas M Roberts

STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer

G. Freeman, U. Matulonis, Shaozhen Xie, 2022, Journal for ImmunoTherapy of Cancer.

Functional characterization of an isoform-selective inhibitor of PI3K-p110β as a potential anticancer agent.

N. Gray, Qingsong Liu, C. Benes, 2012, Cancer discovery.

Human cdc2 protein kinase is a major cell-cycle regulated tyrosine kinase substrate

D. Morrison, H. Piwnica-Worms, D. Beach, 1988, Nature.

PI3Kβ controls immune evasion in PTEN-deficient breast tumours

G. Freeman, S. Prakadan, A. Shalek, 2023, Nature.

Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK–ERK independent mechanism

Jing Chen, Katsunori Fujii, H. Fu, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Oridonin inhibits aberrant AKT activation in breast cancer

J. Clardy, H. Cheung, Jean J. Zhao, 2018, Oncotarget.

The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase

L. Cantley, D. Morrison, L. Varticovski, 1989, Nature.

COVID-19 vaccines elicit strong cellular immunity and robust clinical protection in CLL

R. Bruton, S. Faustini, B. Willett, 2022, Cancer Cell.